Can small molecule GLP-1 agonists be the next first-line drugs in type-2 diabetes mellitus?

J Basic Clin Physiol Pharmacol · 2023

Last updated 2026-09-22

Journal	J Basic Clin Physiol Pharmacol, 2023
Citations	2
Relative citation ratio	0.14
NIH percentile	10
Molecules	—
Conditions studied	Type 2 Diabetes

Full record and abstract on PubMed 38048046 ↗